🎉 M&A multiples are live!
Check it out!

Boston Scientific Valuation Multiples

Discover revenue and EBITDA valuation multiples for Boston Scientific and similar public comparables like Myomo, Philips, and InfuSystem.

Boston Scientific Overview

About Boston Scientific

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.


Founded

1979

HQ

United States of America
Employees

53K+

Financials

LTM Revenue $17.2B

LTM EBITDA $5.1B

EV

$154B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Boston Scientific Financials

Boston Scientific has a last 12-month revenue of $17.2B and a last 12-month EBITDA of $5.1B.

In the most recent fiscal year, Boston Scientific achieved revenue of $16.7B and an EBITDA of $3.9B.

Boston Scientific expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Boston Scientific valuation multiples based on analyst estimates

Boston Scientific P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $14.2B $16.7B XXX XXX XXX
Gross Profit $8.7B $9.9B XXX XXX XXX
Gross Margin 61% 59% XXX XXX XXX
EBITDA $3.4B $3.9B XXX XXX XXX
EBITDA Margin 24% 23% XXX XXX XXX
Net Profit $698M $1.6B XXX XXX XXX
Net Margin 5% 10% XXX XXX XXX
Net Debt $8.0B $8.2B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Boston Scientific Stock Performance

As of March 17, 2025, Boston Scientific's stock price is $97.

Boston Scientific has current market cap of $143B, and EV of $154B.

See Boston Scientific trading valuation data

Boston Scientific Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$154B $143B XXX XXX XXX XXX $2.58

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Boston Scientific Valuation Multiples

As of March 17, 2025, Boston Scientific has market cap of $143B and EV of $154B.

Boston Scientific's trades at 8.9x LTM EV/Revenue multiple, and 30.1x LTM EBITDA.

Analysts estimate Boston Scientific's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Boston Scientific and 10K+ public comps

Boston Scientific Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $154B XXX XXX XXX
EV/Revenue 9.2x XXX XXX XXX
EV/EBITDA 40.0x XXX XXX XXX
P/E 77.3x XXX XXX XXX
P/E/Growth 1.2x XXX XXX XXX
EV/FCF 65.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Boston Scientific Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Boston Scientific Valuation Multiples

Boston Scientific's NTM/LTM revenue growth is 13%

Boston Scientific's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Boston Scientific's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Boston Scientific's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Boston Scientific and other 10K+ public comps

Boston Scientific Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 18% XXX XXX XXX XXX
EBITDA Margin 23% XXX XXX XXX XXX
EBITDA Growth 12% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 36% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 10% XXX XXX XXX XXX
Opex to Revenue 51% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Boston Scientific Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Boston Scientific M&A and Investment Activity

Boston Scientific acquired  XXX companies to date.

Last acquisition by Boston Scientific was  XXXXXXXX, XXXXX XXXXX XXXXXX . Boston Scientific acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Boston Scientific

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Boston Scientific

When was Boston Scientific founded? Boston Scientific was founded in 1979.
Where is Boston Scientific headquartered? Boston Scientific is headquartered in United States of America.
How many employees does Boston Scientific have? As of today, Boston Scientific has 53K+ employees.
Who is the CEO of Boston Scientific? Boston Scientific's CEO is Mr. Michael F. Mahoney.
Is Boston Scientific publicy listed? Yes, Boston Scientific is a public company listed on NYS.
What is the stock symbol of Boston Scientific? Boston Scientific trades under BSX ticker.
When did Boston Scientific go public? Boston Scientific went public in 1992.
Who are competitors of Boston Scientific? Similar companies to Boston Scientific include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Boston Scientific? Boston Scientific's current market cap is $143B
What is the current revenue of Boston Scientific? Boston Scientific's last 12-month revenue is $17.2B.
What is the current EBITDA of Boston Scientific? Boston Scientific's last 12-month EBITDA is $5.1B.
What is the current EV/Revenue multiple of Boston Scientific? Current revenue multiple of Boston Scientific is 8.9x.
What is the current EV/EBITDA multiple of Boston Scientific? Current EBITDA multiple of Boston Scientific is 30.1x.
What is the current revenue growth of Boston Scientific? Boston Scientific revenue growth between 2023 and 2024 was 18%.
Is Boston Scientific profitable? Yes, Boston Scientific is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.